Shares of Definitive Healthcare Corp. (NASDAQ:DH – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twelve analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and three have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $5.72.
Several research firms recently weighed in on DH. BTIG Research assumed coverage on Definitive Healthcare in a report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 target price for the company. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. Finally, Stephens assumed coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 target price on the stock.
Read Our Latest Research Report on Definitive Healthcare
Insider Activity
Institutional Investors Weigh In On Definitive Healthcare
A number of institutional investors have recently bought and sold shares of DH. Point72 DIFC Ltd lifted its holdings in shares of Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after acquiring an additional 8,215 shares during the period. Intech Investment Management LLC acquired a new position in Definitive Healthcare in the third quarter worth about $55,000. Sanctuary Advisors LLC bought a new position in Definitive Healthcare during the second quarter worth about $85,000. Bleakley Financial Group LLC bought a new position in Definitive Healthcare during the third quarter worth about $74,000. Finally, Glenmede Trust Co. NA boosted its holdings in Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock valued at $82,000 after purchasing an additional 5,362 shares in the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.
Definitive Healthcare Price Performance
NASDAQ DH opened at $4.12 on Friday. Definitive Healthcare has a fifty-two week low of $3.19 and a fifty-two week high of $10.62. The stock’s 50-day moving average is $4.36 and its two-hundred day moving average is $4.59. The firm has a market cap of $475.95 million, a P/E ratio of -1.33, a price-to-earnings-growth ratio of 3.29 and a beta of 1.40. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49.
About Definitive Healthcare
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Further Reading
- Five stocks we like better than Definitive Healthcare
- What is the Shanghai Stock Exchange Composite Index?
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- What Are the FAANG Stocks and Are They Good Investments?
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- How to Buy Cheap Stocks Step by Step
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.